Lotus Pharmaceutical Co., Ltd.
1795Pharmaceuticals
NT$172.50−0.86%As of Oct 29vs prior close
- Market cap
- $1.4B
- P/E (TTM)
- 12.2×
- P/E (FY1)
- 13.1×
- From 52W high
- −51.20%
- EPS (LTM)
- NT$14.22
- Revenue (LTM)
- NT$28.5B
- Net margin
- 13.22%
- Dividend yield
- 1.49%
Nomior Score
45
Steady ProfileBottom 39% of the scored universe
Growth67
Quality48
Value63
Momentum14
Resilience46
Growth
+11.91%revenue a year over 3 fiscal years
YE22 NT$14.6BLTM NT$28.5B
Connections
Revenue to profitYE25
23% of revenue became net profit, down 4 pts on a year.